Agios Pharmaceuticals (AGIO) Non Operating Income (2022 - 2026)
Agios Pharmaceuticals' (AGIO) quarterly Non Operating Income came in at $9.7 million in Q2 2026, down 32.96% YoY from $14.5 million in Q2 2025, and down 9.87% on a QoQ basis from $10.8 million in Q1 2026.
Agios Pharmaceuticals (AGIO) Non Operating Income (2022 - 2026) Analysis & Trends
Agios Pharmaceuticals (AGIO) has 5 years of Non Operating Income data on file, last reported at $9.7 million in Q2 2026.
- Quarterly Non Operating Income fell 32.96% year-over-year to $9.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $46.3 million (down 24.92% YoY) and the FY2025 annual result came in at $56.4 million, up 17.25% from the prior year.
- Non Operating Income slipped to $9.7 million in Q2 2026, from $10.8 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $18.0 million in Q4 2024 to a low of $3.8 million in Q3 2022.
- A 5-year average of $10.5 million and a median of $9.3 million in 2024 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2023 — Non Operating Income surged 119.36% — and 2026, when it tumbled 32.96%.
- Tracing AGIO's Non Operating Income over 5 years: stood at $6.5 million in 2022, then jumped by 32.92% to $8.6 million in 2023, then jumped by 108.89% to $18.0 million in 2024, then tumbled by 31.11% to $12.4 million in 2025, then fell by 21.6% to $9.7 million in 2026.
- The last three Non Operating Income figures came in at $9.7 million (Q2 2026), $10.8 million (Q1 2026), and $12.4 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Agios Pharmaceuticals | 2.00 Bn | 1.38 Bn | 41.75 Mn | 9.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.73 Mn |
| Mar 31, 2026 | 10.80 Mn |
| Dec 31, 2025 | 12.41 Mn |
| Sep 30, 2025 | 13.37 Mn |
| Jun 30, 2025 | 14.51 Mn |
| Mar 31, 2025 | 16.09 Mn |
| Dec 31, 2024 | 18.02 Mn |
| Sep 30, 2024 | 13.06 Mn |
| Jun 30, 2024 | 8.12 Mn |
| Mar 31, 2024 | 8.89 Mn |
| Dec 31, 2023 | 8.62 Mn |
| Sep 30, 2023 | 8.38 Mn |
| Jun 30, 2023 | 8.25 Mn |
| Mar 31, 2023 | 8.09 Mn |
| Dec 31, 2022 | 6.49 Mn |
| Sep 30, 2022 | 3.82 Mn |